Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Godavari Drugs is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
GODAVARI DRUGS LTD. - 530317 - Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Thursday 14Th November, 2024 | Download
GODAVARI DRUGS LTD. - 530317 - Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Thursday 14Th November, 2024 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant